Cargando…
Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence
Safety-related drug failures remain a major challenge for the pharmaceutical industry. One approach to ensuring drug safety involves assessing small molecule drug specificity by examining the ability of a drug candidate to interact with a panel of “off-target” proteins, referred to as secondary phar...
Autores principales: | Deaton, Aimee M, Fan, Fan, Zhang, Wei, Nguyen, Phuong A, Ward, Lucas D, Nioi, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358245/ https://www.ncbi.nlm.nih.gov/pubmed/30346593 http://dx.doi.org/10.1093/toxsci/kfy265 |
Ejemplares similares
-
Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting
por: Bao, Minghui, et al.
Publicado: (2020) -
Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021) -
Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives
por: Salikhanov, Islam, et al.
Publicado: (2022) -
Screening for ROP
por: Quinn, Graham, et al.
Publicado: (2017) -
Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries
por: Mallafré-Larrosa, Meritxell, et al.
Publicado: (2023)